Tempus, a leader in artificial intelligence and precision medicine, announced that the U.S. Food & Drug Administration (FDA) has granted the company Breakthrough Device...
Athos Therapeutics, Inc. ("Athos"), a late-stage preclinical biotech company using artificial intelligence to develop small molecule therapeutics for immune-mediated diseases and cancer, announced a...
Red Cell Partners (“Red Cell”), an investment and incubation firm that backs, builds, and scales technology-led companies in healthcare and defense, today announced the...
